1. Academic Validation
  2. Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1

Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1

  • Hum Mol Genet. 2010 Apr 1;19(7):1165-73. doi: 10.1093/hmg/ddp587.
Christina A Gurnett 1 David M Desruisseau Kevin McCall Ryan Choi Zachary I Meyer Michael Talerico Sara E Miller Jeong-Sun Ju Alan Pestronk Anne M Connolly Todd E Druley Conrad C Weihl Mathew B Dobbs
Affiliations

Affiliation

  • 1 Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA. gurnettc@neuro.wustl.edu
Abstract

Distal arthrogryposis type I (DA1) is a disorder characterized by congenital contractures of the hands and feet for which few genes have been identified. Here we describe a five-generation family with DA1 segregating as an autosomal dominant disorder with complete penetrance. Genome-wide linkage analysis using Affymetrix GeneChip Mapping 10K data from 12 affected members of this family revealed a multipoint LOD(max) of 3.27 on chromosome 12q. Sequencing of the slow-twitch skeletal muscle Myosin binding protein C1 (MYBPC1), located within the linkage interval, revealed a missense mutation (c.706T>C) that segregated with disease in this family and causes a W236R amino acid substitution. A second MYBPC1 missense mutation was identified (c.2566T>C)(Y856H) in another family with DA1, accounting for an MYBPC1 mutation frequency of 13% (two of 15). Skeletal muscle biopsies from affected patients showed type I (slow-twitch) fibers were smaller than type II fibers. Expression of a green Fluorescent protein (GFP)-tagged MYBPC1 construct containing WT and DA1 mutations in mouse skeletal muscle revealed robust sarcomeric localization. In contrast, a more diffuse localization was seen when non-fused GFP and MYBPC1 proteins containing corresponding MYBPC3 amino acid substitutions (R326Q, E334K) that cause hypertrophic cardiomyopathy were expressed. These findings reveal that the MYBPC1 is a novel gene responsible for DA1, though the mechanism of disease may differ from how some cardiac MYBPC3 mutations cause hypertrophic cardiomyopathy.

Figures